Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

Keywords

Trichostatin A, Experimental autoimmune encephalomyelitis, Histone deacetylase, Histone deacetylase inhibitor, Neurodegeneration

References

• Cloning and characterization of the rat glutathione peroxidase geneManuel Antonio González de la Rosa, Miguel Ángel Serrano García, Pedro Ignacio Cardona Guerra — 1992
• Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple SclerosisJerome R. Wujek, Carl Bjartmar, Edward Richer — 2002
• Sodium Phenylacetate Inhibits Adoptive Transfer of Experimental Allergic Encephalomyelitis in SJL/J Mice at Multiple Steps1Subhajit Dasgupta, You Zhou, Malabendu Jana — 2003
• Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptakeTimothy H. Murphy, Ronald L. Schnaar, Joseph T. Coyle — 1990
• A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis : inflammation versus degeneration.Zubair Ahmed, Anne I. Doward, Gareth Pryce — 2002
• Acute Neuronal Apoptosis in a Rat Model of Multiple SclerosisRoman Meyer, Robert Weissert, Ricarda Diem — 2001
• Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in RemyelinationJeffrey L. Mason, Shouhong Xuan, Ioannis Dragatsis — 2003
• Sp1 and Sp3 Are Oxidative Stress-Inducible, Antideath Transcription Factors in Cortical NeuronsHoon Ryu, Junghee Lee, Khalequz Zaman — 2003
• The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responsesJosé M.A. Moreira, Peter Scheipers, Poul Sørensen — 2003
• Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseaseEmma Hockly, Victoria M. Richon, Benjamin Woodman — 2003
• Chemokine Upregulation Follows Cytokine Expression in Chronic Relapsing Experimental Autoimmune EncephalomyelitisAndrzej Głąbiński, Bartosz Bielecki, R. M. Ransohoff — 2003
• Regulation of neuronal traits by a novel transcriptional complex.Nurit Ballas, Elena Battaglioli, Fouad Atouf — 2001
• The Regulation of Reactive Oxygen Species Production during Programmed Cell DeathShirlee Tan, Yutaka Sagara, Yuanbin Liu — 1998
• Identification of novel E2F1-regulated genes by microarray.Yihong Ma, Rhonda Croxton, Ronnie L. Moorer — 2002
• Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesionsJohn W. Peterson, Lars Eirik Bø, Sverre Mørk — 2001
• The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseSawsan Youssef, Olaf Stüve, Juan C. Patarroyo — 2002
• Glutathione Peroxidase Protects against Peroxynitrite-mediated OxidationsHelmut Sies, Victor S. Sharov, Lars‐Oliver Klotz — 1997
• Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.Paul Brennan, J. W. Babbage, Boudewijn Burgering — 1997
• Glutathione deficiency leads to mitochondrial damage in brain.A Jain, Jerker Mårtensson, Einar Stole — 1991
• Insights into glutamate transport regulation in human astrocytes: Cloning of the promoter for excitatory amino acid transporter 2 (EAAT2)Zao-zhong Su, Magdalena Leszczyniecka, Dong‐Chul Kang — 2003

Cited by

• HDAC inhibitors as anti‐inflammatory agentsA.I. Bertinov, D.A. But, L.K. Kovalev — 2007
• Development of histone deacetylase inhibitors for cancer treatmentPer Bergling — 2007
• Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll‐like receptor 4 agonist LPSManuel Paz de Santos — 2010
• 4-iodophenyl isothiocyanate: A neuroprotective compoundDeepak Kumar Mahapatra — 2012
• Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damageMaria Helena Oliveira Sampa, Erzsébet Takács, P. Gehringer — 2011
• Epigenetics in sepsis: targeting histone deacetylases.Е. В. Хазова, О. В. Булашова, В М Газизянова — 2013
• Prospects for epigenetic compounds in the treatment of autoimmune disease.Nadine Chapman‐Rothe, Robert Brown — 2011
• Histone Deacetylase Inhibitors as Therapeutic Agents for Acute Central Nervous System InjuriesNa’ama A. Shein, Esther Shohami — 2011
• Rationale for HDAC inhibitor therapy in autoimmunity and transplantation.Wayne W. Hancock — 2011
• Regulierung der Funktion Dendritischer Zellen durch Histon-Deacetylase-InhibitorenJulia Beck — 2009
• Role of epigenetics in inflammation-associated diseases.Muthu K. Shanmugam, Gautam Sethi — 2013
• Creating a Pro-survival and Anti-inflammatory Phenotype by Modulation of Acetylation in Models of Hemorrhagic and Septic ShockYongqing Li, Hasan B. Alam — 2012
• Apicidin, the Histone Deacetylase Inhibitor, Suppresses TH1 Polarization of Murine Bone Marrow-Derived Dendritic CellsIl-Hyo Jung, J.S. Lee, Y-I. Jeong — 2009
• Histone Deacetylase (HDAC) Inhibition as a Novel Treatment for Diabetes MellitusDan Ploug Christensen, Mattias Salling Dahllöf, Morten Lundh — 2011
• Transcriptional regulatory mechanisms involved in CYP46A1 up-regulation by histone deacetylase inhibitors:from chromatin structure to transcription factorsM. J. Nunes — 2012
• Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disorders.Matthew W. Lawless, Suzanne Norris, Kenneth J. O’Byrne — 2009
• Nutrients and EpigeneticsSang-Woon Choi, S. Friso — 2009
• HDAC inhibition as a therapeutic potential to treat metabolic diseasesVidhi Gaur — 2013
• Metabolism and epigenetics in the nervous system: Creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenasesSaravanan S. Karuppagounder, Amit Kumar, Diana S. Shao — 2015
• n‐Butyrate Anergized Effector CD4+ T Cells Independent of Regulatory T cell Generation or ActivityB. M. FONTENELLE, Katabarwa Murenzi Gilbert — 2012

Related papers

• mHDA1/HDAC5 Histone Deacetylase Interacts with and Represses MEF2A Transcriptional Activity*Claudie Lemercier, André Verdel, Bertrand Galloo — 2000
• Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo.David Kadosh, Kevin Struhl — 1998
• Cytotoxicity and gene expression induced by histone deacetylase inhibitor, trichostatin A, on human hepatoma cellsTetsuhiro Chiba, Osamu Yokosuka, Kenichi Fukai — 2003
• Inhibition of PGC-1β expression by the class II histone deacetylase HDAC5Michael P. Czubryt, Bernard Abrenica, Lise Lamoureux — 2007
• Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin ATomoyuki Miyashita, Hideyuki Yamamoto, Yoshitake Nishimune — 1994
• The histone deacetylase inhibitor trichostatin A influences the development of Drosophila melanogasterLori A. Pile, F.W.-H. Lee, David A. Wassarman — 2001
• Nonsteroidal Anti-inflammatory Drug-activated Gene (NAG-1/GDF15) Expression Is Increased by the Histone Deacetylase Inhibitor Trichostatin A*Hiroki Yoshioka, Hideki Kamitani, Takashi Watanabe — 2008
• Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.Anoushe Sekhavat, Jianmin Sun, James Davie — 2007
• Genes Are Often Sheltered from the Global Histone Hyperacetylation Induced by HDAC InhibitorsJohn A. Halsall, Vibhor Gupta, Laura P. O’Neill — 2012